Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - TOTAL RECEIVABLES
Total Receivables REGN - Regeneron Pharmaceuticals, Inc.
5.67 B
LAST VALUE
-3.11%
2 YEAR CAGR
20.37%
5 YEAR CAGR
19.49%
10 YEAR CAGR